Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1526381

Cover Image

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1526381

Global Facial Injectable Market Share, Size, Trends, Industry Analysis Report: Information By Product, By Application, By End-Use, And By Region - Market Forecast, 2024 - 2032

PUBLISHED:
PAGES: 117 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Multi User License)
USD 5250
PDF (Enterprise License)
USD 6250

Add to Cart

The global facial injectable market size is expected to reach USD 33.63 billion by 2032, according to a new study by Polaris Market Research. The report "Global Facial Injectable Market Share, Size, Trends, Industry Analysis Report: Information By Product, By Application, By End-Use (MedSpa, Dermatology Clinics, Hospitals), And By Region (North America, Europe, Asia-Pacific, Middle East & Africa, And Latin America) - Market Forecast, 2024 - 2032." gives a detailed insight into current market dynamics and provides analysis on future market growth.

The demand for facial injectables is rapidly increasing due to the introduction of cost-effective procedures that have significantly expanded the market's demand. Products offer accessible options for consumers seeking aesthetic enhancements without high costs, thus widening the customer base and increasing overall market penetration.

Moreover, the growing demand for facial injectables is driven by increased regulatory approvals, that ensures safety, effectiveness and make treatments more accessible and appealing to a broader range of consumers. For instance, in May 2023, AbbVie announced the FDA approval of Juvederm's Skinvive to improve skin smoothness in the cheeks. This approval emphasizes the growing acceptance and innovation in facial injectables, driving market growth and enhancing consumer confidence in treatments.

Furthermore, the overall number of cosmetic procedures, including facial injectables, continues to rise steadily, in turn driving the market revenue. For instance, according to the American Society of Plastic Surgeons (ASPS), in 2022, the United States witnessed 26.2 million surgical and minimally invasive cosmetic procedures, observing a 19% increase since 2019. This rising trends for surgical and minimally invasive cosmetic procedures are driven by advancements in medical technology and improved safety profiles of injectable products. The combination of these factors creates a synergistic effect, boosting demand within the facial injectables market.

Facial Injectable Market Report Highlights

The hyaluronic acid (HA) segment held the largest market share in 2023 due to its widespread adoption for effective cosmetic enhancements.

The lip augmentation is expected to grow fastest over the forecast period, driven by consumer demand for fuller lips, advanced techniques, and diverse product options.

North America was the dominant region in the global facial injectables market in 2023, experiencing significant growth in cosmetic procedures due to non-invasive treatments and product innovations.

The global key market players include Allergan Aesthetics (AbbVie), BIOPLUS CO., LTD., Bioxis Pharmaceuticals, GALDERMA, Ipsen Pharma, Merz Pharma, Medytox, Prollenium Medical Technologies, SINCLAIR PLASTIC SURGERY, and Teoxane

Polaris Market Research has segmented the facial injectable market report based on product, application, end-use and region:

Facial Injectable, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Collagen & PMMA Microspheres
  • Botulinum Toxin Type A
  • Hyaluronic Acid (HA)
  • Calcium Hydroxylapatite (CaHA)
  • Poly-L-lactic Acid (PLLA)
  • Others

Facial Injectable, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Facial Line Correction
  • Lip Augmentation
  • Face Lift
  • Acne Scar Treatment
  • Lipoatrophy Treatment
  • Others

Facial Injectable, End-Use (Revenue - USD Billion, 2019 - 2032)

  • MedSpa
  • Dermatology Clinics
  • Hospitals

Facial Injectable, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Australia
  • Malaysia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa
Product Code: PM1307

Table of Contents

1.Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Facial Injectable Market Insights

  • 4.1. Facial Injectable Market - Application Snapshot
  • 4.2. Facial Injectable Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. High rate of FDA approvals is a significant catalyst for facial injectables market growth
      • 4.2.1.2. Increasing adoption of facial injectables
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Adverse side effects of facial injectables
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Facial Injectable Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Facial Injectable Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • 5.3. Collagen & PMMA Microspheres
    • 5.3.1. Global Facial Injectable Market, by Collagen & PMMA Microspheres, by Region, 2019-2032 (USD Billion)
  • 5.4. Botulinum Toxin Type A
    • 5.4.1. Global Facial Injectable Market, by Botulinum Toxin Type A, by Region, 2019-2032 (USD Billion)
  • 5.5. Hyaluronic Acid (HA)
    • 5.5.1. Global Facial Injectable Market, by Hyaluronic Acid (HA), by Region, 2019-2032 (USD Billion)
  • 5.6. Calcium Hydroxylapatite (CaHA)
    • 5.6.1. Global Facial Injectable Market, by Calcium Hydroxylapatite (CaHA), by Region, 2019-2032 (USD Billion)
  • 5.7. Poly-L-lactic Acid (PLLA)
    • 5.7.1. Global Facial Injectable Market, by Poly-L-lactic Acid (PLLA), by Region, 2019-2032 (USD Billion)
  • 5.8. Others
    • 5.8.1. Global Facial Injectable Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Facial Injectable Market, by End-use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • 6.3. MedSpa
    • 6.3.1. Global Facial Injectable Market, by MedSpa, by Region, 2019-2032 (USD Billion)
  • 6.4. Dermatology Clinics
    • 6.4.1. Global Facial Injectable Market, by Dermatology Clinics, by Region, 2019-2032 (USD Billion)
  • 6.5. Hospitals
    • 6.5.1. Global Facial Injectable Market, by Hospitals, by Region, 2019-2032 (USD Billion)

7. Global Facial Injectable Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • 7.3. Facial Line Correction
    • 7.3.1. Global Facial Injectable Market, by Facial Line Correction, By Region, 2019-2032 (USD Billion)
  • 7.4. Lip Augmentation
    • 7.4.1. Global Facial Injectable Market, by Lip Augmentation, By Region, 2019-2032 (USD Billion)
  • 7.5. Face Lift
    • 7.5.1. Global Facial Injectable Market, by Face Lift, By Region, 2019-2032 (USD Billion)
  • 7.6. Acne Scar Treatment
    • 7.6.1. Global Facial Injectable Market, by Acne Scar Treatment, By Region, 2019-2032 (USD Billion)
  • 7.7. Lipoatrophy Treatment
    • 7.7.1. Global Facial Injectable Market, by Lipoatrophy Treatment, By Region, 2019-2032 (USD Billion)
  • 7.8. Others
    • 7.8.1. Global Facial Injectable Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Facial Injectable Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Facial Injectable Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Facial Injectable Market - North America
    • 8.3.1. North America: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
    • 8.3.2. North America: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
    • 8.3.3. North America: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.3.4. Facial Injectable Market - U.S.
      • 8.3.4.1. U.S.: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.3.5. Facial Injectable Market - Canada
      • 8.3.5.1. Canada: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • 8.4. Facial Injectable Market - Europe
    • 8.4.1. Europe: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.4.4. Facial Injectable Market - UK
      • 8.4.4.1. UK: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.4.5. Facial Injectable Market - France
      • 8.4.5.1. France: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.4.6. Facial Injectable Market - Germany
      • 8.4.6.1. Germany: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.4.7. Facial Injectable Market - Italy
      • 8.4.7.1. Italy: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.4.8. Facial Injectable Market - Spain
      • 8.4.8.1. Spain: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.4.9. Facial Injectable Market - Netherlands
      • 8.4.9.1. Netherlands: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.4.10. Facial Injectable Market - Russia
      • 8.4.10.1. Russia: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.4.11. Facial Injectable Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.4.11.2. Rest of Europe.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.4.11.3. Rest of Europe: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • 8.5. Facial Injectable Market - Asia Pacific
    • 8.5.1. Asia Pacific: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.5.4. Facial Injectable Market - China
      • 8.5.4.1. China: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.5.5. Facial Injectable Market - India
      • 8.5.5.1. India: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.5.6. Facial Injectable Market - Malaysia
      • 8.5.6.1. Malaysia: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.5.7. Facial Injectable Market - Japan
      • 8.5.7.1. Japan: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.5.8. Facial Injectable Market - Indonesia
      • 8.5.8.1. Indonesia: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.5.9. Facial Injectable Market - South Korea
      • 8.5.9.1. South Korea: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.5.10. Facial Injectable Market - Australia
      • 8.5.10.1. Australia: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.5.10.2. Australia: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.5.10.3. Australia: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.5.11. Facial Injectable Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • 8.6. Facial Injectable Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.6.4. Facial Injectable Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.6.5. Facial Injectable Market - UAE
      • 8.6.5.1. UAE: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.6.6. Facial Injectable Market - Israel
      • 8.6.6.1. Israel: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.6.7. Facial Injectable Market - South Africa
      • 8.6.7.1. South Africa: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.6.8. Facial Injectable Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • 8.7. Facial Injectable Market - Latin America
    • 8.7.1. Latin America: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.7.4. Facial Injectable Market - Mexico
      • 8.7.4.1. Mexico: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.7.5. Facial Injectable Market - Brazil
      • 8.7.5.1. Brazil: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.7.6. Facial Injectable Market - Argentina
      • 8.7.6.1. Argentina: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
    • 8.7.7. Facial Injectable Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
      • 8.7.7.2. Rest of Latin America.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Allergan Aesthetics (AbbVie Inc.)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. BIOPLUS CO., LTD.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Bioxis Pharmaceuticals
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. GALDERMA
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Ipsen Pharma
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Merz Pharma
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Medytox
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Prollenium Medical Technologies
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. SINCLAIR PLASTIC SURGERY
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Teoxane
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
Product Code: PM1307

List of Tables

  • Table 1 Global Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 2 Global Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 3 Global Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 4 Facial Injectable Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 6 North America: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 7 North America: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 8 U.S.: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 9 U.S.: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 10 U.S.: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 11 Canada: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 12 Canada: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 13 Canada: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 14 Europe: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 15 Europe: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 16 Europe: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 17 UK: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 18 UK: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 19 UK: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 20 France: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 21 France: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 22 France: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 23 Germany: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 24 Germany: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 25 Germany: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 26 Italy: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 27 Italy: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 28 Italy: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 29 Spain: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 30 Spain: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 31 Spain: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 35 Russia: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 36 Russia: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 37 Russia: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 38 Rest of Europe: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 39 Rest of Europe: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 40 Rest of Europe: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 41 Asia Pacific: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 42 Asia Pacific: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 43 Asia Pacific: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 44 China: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 45 China: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 46 China: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 47 India: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 48 India: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 49 India: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 50 Malaysia: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 51 Malaysia: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 52 Malaysia: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 53 Japan: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 54 Japan: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 55 Japan: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 56 Indonesia: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 57 Indonesia: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 58 Indonesia: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 59 South Korea: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 60 South Korea: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 61 South Korea: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 62 Australia: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 63 Australia: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 64 Australia: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 65 Rest of Asia Pacific: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 66 Rest of Asia Pacific: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 67 Rest of Asia Pacific: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 68 Middle East & Africa: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 69 Middle East & Africa: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 70 Middle East & Africa: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 71 Saudi Arabia: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 72 Saudi Arabia: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 73 Saudi Arabia: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 74 UAE: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 75 UAE: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 76 UAE: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 77 Israel: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 78 Israel: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 79 Israel: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 80 South Africa: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 81 South Africa: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 82 South Africa: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 85 Rest of Middle East & Africa: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 86 Latin America: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 87 Latin America: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 88 Latin America: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 89 Mexico: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 90 Mexico: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 91 Mexico: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 92 Brazil: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 93 Brazil: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 94 Brazil: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 95 Argentina: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 96 Argentina: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 97 Argentina: Facial Injectable Market, by Application, 2019-2032 (USD Billion)
  • Table 98 Rest of Latin America: Facial Injectable Market, by Product, 2019-2032 (USD Billion)
  • Table 99 Rest of Latin America: Facial Injectable Market, by End-use, 2019-2032 (USD Billion)
  • Table 100 Rest of Latin America: Facial Injectable Market, by Application, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Facial Injectable Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by End-use
  • Figure 7. Global Facial Injectable Market, by End-use, 2023 & 2032 (USD Billion)
  • Figure 8. Market by Product
  • Figure 9. Global Facial Injectable Market, by Product, 2023 & 2032 (USD Billion)
  • Figure 10. Market by Application
  • Figure 11. Global Facial Injectable Market, by Application, 2023 & 2032 (USD Billion)
  • Figure 12. Facial Injectable Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Facial Injectable Market
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!